SCHEMBL13258593

COc1ccc2c(c1)C=C(c1c(C(=O)N3C4CCC3CC(C)(O)C4)cnn1C(C)C)Cn1c-2c(C2CCCCC2)c2ccc(C(=O)NS(=O)(=O)C(C)C)cc21

nearest known ligand 0.53

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	KCNH2	Q12809	7/20	0.53

▸	NR1I2	O75469	10/20	0.45

▸	CYP3A4	P08684	3/20	0.42

▸	SCN5A	Q14524	2/20	0.42

▸	CYP2C9	P11712	1/20	0.40

▸	CYP2C19	P33261	1/20	0.40

▸	SCN9A	Q15858	3/20	0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL862998	1.00	KCNH2 (0.53)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL862999	0.94	KCNH2 (0.55)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL13531105	0.94	KCNH2 (0.55)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL862872	0.94	KCNH2 (0.55)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL327507	0.93	KCNH2 (0.53)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL277737	0.93	KCNH2 (0.53)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL862645	0.92	KCNH2 (0.60)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL862774	0.92	KCNH2 (0.51)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL272471	0.91	KCNH2 (0.54)	KCNH2NR1I2CYP3A4SCN5ACYP2C9
SCHEMBL841310	0.91	KCNH2 (0.49)	KCNH2NR1I2CYP3A4SCN5ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
WO-2010093359-A1	COMPOUNDS FOR THE TREATMENT OF HEPATITIS C	BRISTOL-MYERS SQUIBB COMPANY (US)	2010-08-19	—	—	WO	disclosed
WO-2009029384-A2	COMPOUNDS FOR THE TREATMENT OF HEPATITIS C	BRISTOL-MYERS SQUIBB COMPANY (US)	2009-03-05	—	—	WO	disclosed